Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice

Copyright © 2022 Sonia Sanchez-Bezanilla et al.

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2022(2022) vom: 08., Seite 9983042
1. Verfasser: Sanchez-Bezanilla, Sonia (VerfasserIn)
Weitere Verfasser: Beard, Daniel J, Hood, Rebecca J, Åberg, N David, Crock, Patricia, Walker, Frederick R, Nilsson, Michael, Isgaard, Jörgen, Ong, Lin Kooi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Brain-Derived Neurotrophic Factor Human Growth Hormone 12629-01-5 Growth Hormone 9002-72-6 Ribosomal Protein S6 Kinases, 70-kDa EC 2.7.11.1 TOR Serine-Threonine Kinases
LEADER 01000caa a22002652c 4500
001 NLM33994515X
003 DE-627
005 20250303070410.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1155/2022/9983042  |2 doi 
028 5 2 |a pubmed25n1132.xml 
035 |a (DE-627)NLM33994515X 
035 |a (NLM)35465399 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sanchez-Bezanilla, Sonia  |e verfasserin  |4 aut 
245 1 0 |a Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 26.04.2022 
500 |a Date Revised 16.07.2022 
500 |a published: Electronic-eCollection 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2022 Sonia Sanchez-Bezanilla et al. 
520 |a Aims: We have shown that growth hormone (GH) treatment poststroke increases neuroplasticity in peri-infarct areas and the hippocampus, improving motor and cognitive outcomes. We aimed to explore the mechanisms of GH treatment by investigating how GH modulates pathways known to induce neuroplasticity, focusing on association between brain-derived neurotrophic factor (BDNF) and mammalian target of rapamycin (mTOR) in the peri-infarct area, hippocampus, and thalamus 
520 |a Methods: Recombinant human growth hormone (r-hGH) or saline was delivered (0.25 μl/hr, 0.04 mg/day) to mice for 28 days, commencing 48 hours after photothrombotic stroke. Protein levels of pro-BDNF, total-mTOR, phosphorylated-mTOR, total-p70S6K, and phosporylated-p70S6K within the peri-infarct area, hippocampus, and thalamus were evaluated by western blotting at 30 days poststroke 
520 |a Results: r-hGH treatment significantly increased pro-BDNF in peri-infarct area, hippocampus, and thalamus (p < 0.01). r-hGH treatment significantly increased expression levels of total-mTOR in the peri-infarct area and thalamus (p < 0.05). r-hGH treatment significantly increased expression of total-p70S6K in the hippocampus (p < 0.05) 
520 |a Conclusion: r-hGH increases pro-BDNF within the peri-infarct area and regions that are known to experience secondary neurodegeneration after stroke. Upregulation of total-mTOR protein expression in the peri-infarct and thalamus suggests that this might be a pathway that is involved in the neurorestorative effects previously reported in these animals and warrants further investigation. These findings suggest region-specific mechanisms of action of GH treatment and provide further understanding for how GH treatment promotes neurorestorative effects after stroke 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Brain-Derived Neurotrophic Factor  |2 NLM 
650 7 |a Human Growth Hormone  |2 NLM 
650 7 |a 12629-01-5  |2 NLM 
650 7 |a Growth Hormone  |2 NLM 
650 7 |a 9002-72-6  |2 NLM 
650 7 |a Ribosomal Protein S6 Kinases, 70-kDa  |2 NLM 
650 7 |a EC 2.7.11.1  |2 NLM 
650 7 |a TOR Serine-Threonine Kinases  |2 NLM 
650 7 |a EC 2.7.11.1  |2 NLM 
700 1 |a Beard, Daniel J  |e verfasserin  |4 aut 
700 1 |a Hood, Rebecca J  |e verfasserin  |4 aut 
700 1 |a Åberg, N David  |e verfasserin  |4 aut 
700 1 |a Crock, Patricia  |e verfasserin  |4 aut 
700 1 |a Walker, Frederick R  |e verfasserin  |4 aut 
700 1 |a Nilsson, Michael  |e verfasserin  |4 aut 
700 1 |a Isgaard, Jörgen  |e verfasserin  |4 aut 
700 1 |a Ong, Lin Kooi  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Neural plasticity  |d 1998  |g 2022(2022) vom: 08., Seite 9983042  |w (DE-627)NLM098558390  |x 1687-5443  |7 nnas 
773 1 8 |g volume:2022  |g year:2022  |g day:08  |g pages:9983042 
856 4 0 |u http://dx.doi.org/10.1155/2022/9983042  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2022  |j 2022  |b 08  |h 9983042